CD36 and hepatocellular carcinoma: Gui-Qi Zhu reported that CD36+ CAFs in hepatocellular carcinoma exhibit high lipid metabolism and secrete macrophage migration inhibitory factor via the lipid peroxidation/p38/CEBPs axis, leading to an immunosuppressive TME and tumour stemness26.